This study evaluated a new drug delivery system for local radiotherapy on the base of nanoporous nanodiamond composites (NDC) labeled with β-emitting radionuclide rhenium-188. The biodistribution of labeled compound was assessed after intratumoral The removal of injected activity from muscular tissue was faster as compared with tumor tissue, and declined from 81.06 % to 8.40 % ID for up to 72 h. Therefore, after i.m. injection the accumulation of radioactivity in healthy organs and tissues was slightly higher than after i.t. injection. In conclusion, it was demonstrated that 188 Renanoporous diamond composites had the potential radiotherapeutic significance.
Introduction
Carbon-based nanomaterials such as carbon nanotubes, fullerenes, nanodiamonds, graphene and its derivatives have attracted considerable attention in recent years in nanomedicine due to their unique properties and biocompatibility [1] [2] [3] . It is possible to synthesize composite materials with defined mechanical properties and use them to create vector containers for targeted delivery of drugs and/or radionuclides. 
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Nanodiamond composites (NDC) consists of nanodiamond particles with a mean size of 4-6 nm and a nanosize graphite-like matrix coating the surfaces of the nanodiamond particles and bonding them into a composite [4] . They possess a high biocompatibilty with human cells and a high porosity, which may be used for takeover, storage and long-term emission of drugs and/or radionuclides by creating durable containers.
For example, these containers with synthetic antibacterial drug levofloxacinum suppressed the development of inflammatory processes in osteal tuberculosis in chinchilla rabbits as compared with control group [4] . In addition, NDC allow compensating bone defect, arising from the inflammatory process in the bone [4] . There was also shown the possibility of the composites to target drug delivery to central nervous system [5] . The results from the biodistribution data for each group of mice were expressed as mean value and standard error of the mean (M ± m). Student's t test was used to analyze data throughout all studies between groups at different time points, and p<0.05 was considered statistically significant.
Materials and methods
Biodistribution study of nanoporous NDC labeled with
Results and discussion
The studies revealed a remarkable retention of radioactivity at the site of injection, 
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In blood the highest levels of specific radioactivity were 1.70 % ID/g (at 5 min) and 1.89 % ID/g (at 1 h) after i.t. and i.m. administration, respectively. It is noteworthy that the amount of activity after i.m. injection was slightly higher as compared to that after i.t. injection, except the first term after injection.
In thyroid high uptakes of activity were observed after introducing of 
Conclusion
In summary, the biodistribution data showed the retention of significant part of injected radioactivity mainly at the place of injection after direct intratumoral and intramuscular administration of 188 Re-nanoporous NDC.
However, there are some differences in 188 Re-nanoporous NDC biodistribution after various routes of administration. The higher amount of activity retained in tumor tissue than in muscle. Therefore after i.m. injection soft organs and tissues uptake of activity was more intensive, especially within 3 h after injection. The results demonstrated that 188 Re-nanoporous NDC had the potential for clinical applications in radiotherapy and can be further evaluated for establishing as a radiopharmaceutical for human use. 
